...
首页> 外文期刊>Pakistan journal of medical sciences. >Pre-operative clinical factors predict progression-free survival and tumor recurrence after initial surgery in patients with astrocytomas: A single-center analysis
【24h】

Pre-operative clinical factors predict progression-free survival and tumor recurrence after initial surgery in patients with astrocytomas: A single-center analysis

机译:术前临床因素预测星形细胞瘤患者初次手术后无进展生存率和肿瘤复发:单中心分析

获取原文
           

摘要

Objective: Pre-operative predictive factors of progression-free survival (PFS) and tumor recurrence after initial surgery are important in counseling patients and decision making. Though PFS after initial surgery in patients with low grade astrocytomas has been described, little is described about PFS in patients with different tumor grades. Our objective was to investigate potential predictive factors of PFS, and devise a scale to predict PFS and tumor recurrence after initial surgery in patients with primary and recurrent astrocytomas of low and high tumor grades.Methods: Clinical, radiographic, pathological and treatment data of 62 patients whose initial treatments of primary and recurrent astrocytomas were both surgeries were analyzed, and factors that had significant correlation with PFS was used to devise a scale.Results: Factors significantly related with PFS were: the time from onset of symptoms to clinical and radiological diagnosis of astrocytomas (Spearman correlation coefficient r=0.298, significance level P=0.019) and with the symptoms of seizures (r=0.292, P=0.021). Patients with age between 30 and 40 years had significant longer PFS than the rest age group (P=0.018, oneway ANOVA). A simple scale (from 0 to 3 points) comprised of the three factors distinguished four groups of patients with significant different post-operative PFS (0 point, 8.0 months; 1 point, 13.7 months; 2 points, 18.0 months; 3 points, 34.5 months) (P=0.004, oneway ANOVA).Conclusion: The simple scale we devised comprised of the three pre-operative prognostic factors can significantly distinguish patients with different post-operative survival after initial treatment of astrocytomas with surgery.doi: http://dx.doi.org/10.12669/pjms.301.4110How to cite this:Zheng S, Hou X, Xu S, Pang Q. Pre-operative clinical factors predict progression-free survival and tumor recurrence after initial surgery in patients with astrocytomas: A single-center analysis. Pak J Med Sci 2014;30(1):136-139. doi: http://dx.doi.org/10.12669/pjms.301.4110This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
机译:目的:术前无进展生存期(PFS)和肿瘤复发的预测因素在咨询患者和决策方面具有重要意义。尽管已经描述了低度星形细胞瘤患者初次手术后的PFS,但对于不同肿瘤级别的患者中PFS的描述很少。我们的目的是研究潜在的PFS预测因素,并设计一个量表来预测低和高肿瘤原发性和复发性星形细胞瘤患者初次手术后的PFS和肿瘤复发。方法:临床,影像学,病理学和治疗数据62分析原发性和复发性星形细胞瘤的初始治疗均需手术治疗的患者,并采用与PFS有显着相关性的因素来制定量表。结果:与PFS显着相关的因素有:从症状发作到临床和影像学诊断的时间星形细胞瘤(Spearman相关系数r = 0.298,显着性水平P = 0.019)和癫痫发作的症状(r = 0.292,P = 0.021)。年龄在30至40岁之间的患者的PFS显着长于其余年龄组(P = 0.018,单向ANOVA)。由三个因素组成的简单量表(从0到3分)区分了四组术后PFS显着不同的患者(0分,8.0个月; 1分,13.7个月; 2分,18.0个月; 3分,34.5。结论:我们设计的简单的量表由三个术前预后因素组成,可以显着地区分初次手术治疗星形细胞瘤的患者术后不同生存期。doi:http:// /dx.doi.org/10.12669/pjms.301.4110如何引用此信息:郑S,侯X,徐S,庞Q。术前临床因素可预测星形细胞瘤患者初次手术后的无进展生存率和肿瘤复发:单中心分析。 Pak J Med Sci 2014; 30(1):136-139。 doi:http://dx.doi.org/10.12669/pjms.301.4110这是根据知识共享署名许可(http://creativecommons.org/licenses/by/3.0)的条款分发的开放获取文章,只要适当引用了原始作品,便可以在任何介质中不受限制地使用,分发和复制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号